Since all milestones for 2018 have been achieved, at the start of 2019 Calmark's development project now enters a new phase that is called verification and validation. In order to be able to CE mark the system, all tests must now be done on serially-produced products. First off is the reader that will be produced at Note AB in Norrtälje in a smaller edition as the first step.
Note is specialized in manufacturing that requires high technical competence and flexibility during the product's life cycle. The company holds ISO - 13 485 certification, which is required to manufacture Calmark's reader. Note also has long experience of manufacturing similar products for customers in the medical technology field.
“We are very pleased that the agreement between the companies is now finalized. It will be exciting to receive the first delivery of serially-produced readers that we so far are going to use for our continued internal tests, but which will later also be available in the hospitals for testing newborn babies,” says Anna Söderlund, CEO at Calmark.